The financial burden of hepatocellular carcinoma, the most common type of liver cancer, is high for Medicare beneficiaries in the first year after diagnosis.
A prospective cohort study showed that patients with progression to cirrhosis measured by vibration-controlled transient elastography had a nearly twofold greater risk for poor outcomes or death.